ICMR

No testing will be required for contacts of Confirmed Cases of Covid-19 unless they are identified as high risk based on age or comorbidities.

According to the NIH, the findings show that the vaccine generates antibodies that successfully neutralize the B.1.1.7 (Alpha) and B.1.617 (Delta) forms of SARS-CoV-2, which were initially discovered in the UK and India, respectively.

As per a study, third waves have developed in other nations, such as the United Kingdom and the United States, and are fueled by a variety of reasons.

According to NCDC Director Dr SK Singh, at least 48 Delta Plus Covid cases have been detected in 10 States and the Union Territory of Jammu.

In a major decision, India on Monday, removed convalescent Plasma Therapy from the list of country’s treatment protocol for COVID-19 patients in its revised clinical guidelines.

Haryana Health Minister Anil Vij, who was administered a trial dose of a coronavirus vaccine ‘Covaxin’, has tested positive for the Covid-19 infection.

On October 7, TNI had posted one 100-Word Edit saying "Plasma Therapy not a Gamechanger". Our view was based on the ICMR Panel report. Now, the GoI is mulling removing this as a Covid Treatment option. Plasma Therapy continues across the…

Contrary to the claims made by various state governments, the ICMR (Indian Council of Medical Research) has revealed that there is no benefit of plasma therapy arresting mortality in moderate to severe COVID-19 cases. It also failed to…

TNI Bureau: A viral photo along with a caption has gone viral on Social Media with the claims that Vice President of Bharat Biotech India Ltd (BBIL), Dr V. K. Srinivas took the Corona vaccine clinical trial. "Dr V. K.Srinivas , Vice…

TNI Bureau: In a big development, which may script a new chapter in global medical history, India has set a deadline of August 15 to complete all clinical trials and launch the first-ever COVID-19 vaccine in the country, as per the reports…